No investment advice!
I do this only for practicing.
Most Info on the chart.
We had a nice volume bounce on July 22 due to announced presentation of clinical trial study.
The presentation should be held July 26- 30.
I would trade the possible pre run up until the presentation.
The outcome of it is 50 / 50
Possible entry for this speculative biostock not reaching reverse head and shoulders but if it does catch momentum after the 60fib then it could reverse head and shoulders....indicators bullish
Multiyear trend break under way. Appears to have had a lot of accumulation over the past few days relative to volume it’s traded in the past. If this multiyear trend break not only breaks, but confirms, I think there might be a bigger picture move in tact for a possible test of the 8-10 area. 4.7 break on the daily chart is key for me, but that doesn’t mean that...
No news on April 9th and no filings either. But CYCN jumped to $3.10 after-hours. The initial pop began during the final hours of the afternoon session with a big volume spike that pushed the stock back above $3 for the first time, to the upside, in a few weeks.
A MELAS Phase 2a study is underway. So the market could be waiting for any updated data to shed...
This stock is sitting nicely on daily chart, but what it great a hedge fund owns 71 percent of shares, back in december of 2019 hedge fund bought second round of shares and if you look at chart thats when price moved up, this is a long term call but you should be in profit sooner than later
